Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-023975

Options or other derivatives

  • Chief Executive Officer acquired 353,261 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Adams Catherine Owen Chief Executive Officer 2024-09-23 Grant or award · Stock Option (Right to Buy) +353,261 353,261 D
Loading xslF345X05/form4-09252024_100900.xml…